Skip to main content
Log in

CASE REPORT: Veno-Occlusive Disease (VOD) in Crohn's Disease (CD) Treated with Azathioprine

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Wilmot FC, and Robertson GW: Senecio disease, or cirrhosis of the liver due to senecio poisoning. Lancet, 2:848–849, 1920.

    Google Scholar 

  2. Bras G, Jeliff DB, Stuart KL: Veno-occlusive disease of the liver with non-portal type of cirrhosis occuring in Jamaica. Arch Pathol, 57:285–300, 1954

    Google Scholar 

  3. Schulman H, Gown AM, Nugent M: Hepatic veno-occlusive disease after bone marrowtransplantation-immunohistochemical identification of the material within occluded central venules. Am J Pathol 127:549–558, 1987

    Google Scholar 

  4. Liano F, Moreno A, Matesanz R, Teruel JL, Redondo C, Garcia-Martin F, Orte L, Ortuno J: Veno-occlusive hepatic disease of the liver in renal transplantation is azathioprine the cause? Nephron, 51:509–516, 1989

    Google Scholar 

  5. Bearman SI, et al: Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. Blood 89:1501–1516, 1997

    Google Scholar 

  6. Richardson PG, et al: Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 92:737–744, 1998

    Google Scholar 

  7. DeLeve LD, et al: Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology, 23:589–599, 1996.

    Google Scholar 

  8. Russmann S, et al: Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis. Eur J Gastroenterol Hepatol13:287–290, 2001

    Google Scholar 

  9. Boehme MWJ, et al: Elevated serum levels and reduced immunhistochemical Expression of thrombomodulin in active ulcerative colitis. Gastroenterology 113:107–117, 1997

    Google Scholar 

  10. Stevens TR, et al: Anti-endothelial cell antibodies in inflammatory bowel disease. Dig Dis Sci 38:426–432, 1993

    Google Scholar 

  11. Holtmann M, Schütz M, Galle PR, Neurath MF: Functional relevance of soluble and transmembrane TNF and TNF-signal transduction in gastrointestinal diseases with special reference to inflammatory bowel diseases (submitted)

  12. Levi M, et al: Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 270(8): 975–979, 1993

    Google Scholar 

  13. Koenings KP, McPhedran P, Spiro HM:Thrombosis in inflammatory bowel disease. J Clin Gastroenterol 9:617–621, 1987

    Google Scholar 

  14. Talbot RW, et al: Vascular complications of inflammatory bowel disease. Mayo Clin Proc 61:140–145, 1986

    Google Scholar 

  15. Levy PJ, Tabares AH, Olin JW: Lower extremity arterial occlusions in young patients with Crohn's colitis and premature atherosclerosis: report of six cases. AmJ Gastroenterol 92:494–497,1997

    Google Scholar 

  16. Liebman HA, et al: The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterology, 115:830–834, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holtmann, M., Schreiner, O., Köhler, H. et al. CASE REPORT: Veno-Occlusive Disease (VOD) in Crohn's Disease (CD) Treated with Azathioprine. Dig Dis Sci 48, 1503–1505 (2003). https://doi.org/10.1023/A:1024755521423

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1024755521423

Navigation